{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T18:05:37Z","timestamp":1776276337687,"version":"3.50.1"},"reference-count":43,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,4,4]],"date-time":"2027-04-04T00:00:00Z","timestamp":1806796800000},"content-version":"am","delay-in-days":307,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100009483","name":"Tokyo University of Agriculture and Technology Institute of Global Innovation Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009483","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009035","name":"Program on Open Innovation Platform with Enterprises, Research Institute and Academia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009035","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Virology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.virol.2026.110894","type":"journal-article","created":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T08:06:43Z","timestamp":1774512403000},"page":"110894","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Omicron RBD expressed in E. coli outperforms mammalian-expressed S1 spike protein in generating highly neutralizing anti-SARS-CoV-2 antibodies in mice"],"prefix":"10.1016","volume":"619","author":[{"given":"Zelin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rawiwan","family":"Wongnak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mami","family":"Oba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tetsuya","family":"Mizutani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Monirul Islam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yutaka","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"5","key":"10.1016\/j.virol.2026.110894_bib1","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1038\/s41587-020-0507-2","article-title":"Viral contamination in biologic manufacture and implications for emerging therapies","volume":"38","author":"Barone","year":"2020","journal-title":"Nat. Biotechnol."},{"key":"10.1016\/j.virol.2026.110894_bib2","doi-asserted-by":"crossref","first-page":"13703","DOI":"10.1073\/pnas.96.24.13703","article-title":"Efficient folding of proteins with multiple disulfide bonds in the Escherichia coli cytoplasm","volume":"96","author":"Bessette","year":"1999","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.virol.2026.110894_bib3","doi-asserted-by":"crossref","DOI":"10.3389\/fbioe.2021.630551","article-title":"Challenges associated with the formation of recombinant protein inclusion bodies in Escherichia coli and strategies to address them for industrial applications","volume":"9","author":"Bhatwa","year":"2021","journal-title":"Front. Bioeng. Biotechnol."},{"key":"10.1016\/j.virol.2026.110894_bib4","doi-asserted-by":"crossref","DOI":"10.3390\/ijms232415744","article-title":"An Escherichia coli expressed multi-disulfide bonded SARS-CoV-2 RBD shows native-like biophysical properties and elicits neutralizing antisera in a mouse model","volume":"23","author":"Brindha","year":"2022","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virol.2026.110894_bib5","doi-asserted-by":"crossref","first-page":"648","DOI":"10.4161\/hv.27464","article-title":"Yeast-expressed recombinant protein of the receptor-binding domain in SARS-CoV spike protein with deglycosylated forms as a SARS vaccine candidate","volume":"10","author":"Chen","year":"2014","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.virol.2026.110894_bib6","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1080\/21645515.2016.1219003","article-title":"Vaccine adjuvants: why and how","volume":"12","author":"Christensen","year":"2016","journal-title":"Hum. Vaccines Immunother."},{"key":"10.1016\/j.virol.2026.110894_bib7","series-title":"COVID-19 Cases | WHO COVID-19 Dashboard","year":"2025"},{"key":"10.1016\/j.virol.2026.110894_bib8","doi-asserted-by":"crossref","first-page":"2713","DOI":"10.1128\/IAI.67.6.2713-2719.1999","article-title":"Profiles of Th1 and Th2 cytokines after primary and secondary infection by Schistosoma mansoni in the semipermissive rat host","volume":"67","author":"C\u00eatre","year":"1999","journal-title":"Infect. Immun."},{"key":"10.1016\/j.virol.2026.110894_bib9","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/s41590-021-01068-z","article-title":"Low-dose in vivo protection and neutralization across SARS-CoV-2 variants by monoclonal antibody combinations","volume":"22","author":"Dussupt","year":"2021","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.virol.2026.110894_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1093\/bioinformatics\/btq700","article-title":"DROP: an SVM domain linker predictor trained with optimal features selected by random forest","volume":"27","author":"Ebina","year":"2011","journal-title":"Bioinformatics"},{"key":"10.1016\/j.virol.2026.110894_bib11","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/j.bbapap.2013.12.013","article-title":"Computational prediction and experimental characterization of a \u201csize switch type repacking\u201d during the evolution of dengue envelope protein domain III (ED3)","volume":"1844","author":"Elahi","year":"2014","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.virol.2026.110894_bib12","doi-asserted-by":"crossref","first-page":"2991","DOI":"10.1038\/s41596-018-0075-9","article-title":"Lentiviral transduction of mammalian cells for fast, scalable and high-level production of soluble and membrane proteins","volume":"13","author":"Elegheert","year":"2018","journal-title":"Nat. Protocol."},{"key":"10.1016\/j.virol.2026.110894_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e28326","article-title":"Assessment of the immune interference effects of multivalent vaccine for influenza epidemic strain in 2022-2023 and evaluation of its efficacy","volume":"10","author":"Ga","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/j.virol.2026.110894_bib14","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.149187","article-title":"SARS-CoV-2 vaccines: a triumph of science and collaboration","volume":"6","author":"Golob","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/j.virol.2026.110894_bib15","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-71748-7","article-title":"Analysis of the SARS-CoV-2 spike protein glycan shield reveals implications for immune recognition","volume":"10","author":"Grant","year":"2020","journal-title":"Sci. Rep."},{"key":"10.1016\/j.virol.2026.110894_bib16","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41392-024-01886-1","article-title":"Glycosylation: mechanisms, biological functions and clinical implications","volume":"9","author":"He","year":"2024","journal-title":"Signal Transduct. Targeted Ther."},{"key":"10.1016\/j.virol.2026.110894_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.vaccine.2025.127143","article-title":"Neutralizing antibodies against the Japanese encephalitis virus are produced by a 12 kDa E. coli- expressed envelope protein domain III (EDIII) tagged with a solubility-controlling peptide","volume":"56","author":"Islam","year":"2025","journal-title":"Vaccine"},{"key":"10.1016\/j.virol.2026.110894_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbrc.2024.149919","article-title":"Adjuvant-free parenterally injectable vaccine platform that harnesses previously induced IgG as an antigen delivery carrier","volume":"711","author":"Kawai","year":"2024","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"10.1016\/j.virol.2026.110894_bib19","first-page":"257","article-title":"Gene expression in Mammalian cells and its applications","volume":"3","author":"Khan","year":"2013","journal-title":"Adv Pharm Bull"},{"key":"10.1016\/j.virol.2026.110894_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2022.112816","article-title":"Emergence of SARS-CoV-2 Omicron (B.1.1.529) variant, salient features, high global health concerns and strategies to counter it amid ongoing COVID-19 pandemic","volume":"209","author":"Khandia","year":"2022","journal-title":"Environ. Res."},{"key":"10.1016\/j.virol.2026.110894_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.24418","article-title":"An overview on inactivated and live-attenuated SARS-CoV-2 vaccines","volume":"36","author":"Khoshnood","year":"2022","journal-title":"J. Clin. Lab. Anal."},{"key":"10.1016\/j.virol.2026.110894_bib22","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1038\/s41586-020-2798-3","article-title":"SARS-CoV-2 vaccines in development","volume":"586","author":"Krammer","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virol.2026.110894_bib23","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/j.virol.2026.110894_bib24","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41541-025-01113-0","article-title":"RBD-depleted SARS-CoV-2 spike generates protective immunity in cynomolgus macaques","volume":"10","author":"Letscher","year":"2025","journal-title":"npj Vaccines"},{"key":"10.1016\/j.virol.2026.110894_bib25","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/1475-2859-11-56","article-title":"SHuffle, a novel Escherichia coli protein expression strain capable of correctly folding disulfide bonded proteins in its cytoplasm","volume":"11","author":"Lobstein","year":"2012","journal-title":"Microb. Cell Fact."},{"key":"10.1016\/j.virol.2026.110894_bib26","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1186\/s12889-024-18457-2","article-title":"Correlation of pre-existing comorbidities with disease severity in individuals infected with SARS-COV-2 virus","volume":"24","author":"Maru\u0161i\u0107","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/j.virol.2026.110894_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.109934","article-title":"An insight overview on COVID-19 mRNA vaccines: advantageous, pharmacology, mechanism of action, and prospective considerations","volume":"117","author":"Mirtaleb","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.virol.2026.110894_bib28","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1016\/j.xphs.2022.11.001","article-title":"The storage and In-Use stability of mRNA vaccines and therapeutics: not A cold case","volume":"112","author":"Oude Blenke","year":"2023","journal-title":"J Pharm Sci"},{"key":"10.1016\/j.virol.2026.110894_bib29","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1152\/physiolgenomics.00089.2020","article-title":"The COVID-19 pandemic: a global health crisis","volume":"52","author":"Pollard","year":"2020","journal-title":"Physiol Genomics"},{"key":"10.1016\/j.virol.2026.110894_bib30","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.addr.2021.01.001","article-title":"Recombinant protein vaccines, a proven approach against coronavirus pandemics","volume":"170","author":"Pollet","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.virol.2026.110894_bib31","doi-asserted-by":"crossref","first-page":"eabc8413","DOI":"10.1126\/sciimmunol.abc8413","article-title":"The receptor binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patients","volume":"5","author":"Premkumar","year":"2020","journal-title":"Sci. Immunol."},{"key":"10.1016\/j.virol.2026.110894_bib32","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/j.bbapap.2011.09.001","article-title":"Solubilization and folding of a fully active recombinant Gaussia luciferase with native disulfide bonds by using a SEP-Tag","volume":"1814","author":"Rathnayaka","year":"2011","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.virol.2026.110894_bib33","doi-asserted-by":"crossref","first-page":"172","DOI":"10.3389\/fmicb.2014.00172","article-title":"Recombinant protein expression in Escherichia coli: advances and challenges","volume":"5","author":"Rosano","year":"2014","journal-title":"Front. Microbiol."},{"key":"10.1016\/j.virol.2026.110894_bib34","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s00253-006-0465-8","article-title":"Overview of bacterial expression systems for heterologous protein production: from molecular and biochemical fundamentals to commercial systems","volume":"72","author":"Terpe","year":"2006","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"10.1016\/j.virol.2026.110894_bib35","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.molmed.2022.04.007","article-title":"Adverse effects of COVID-19 mRNA vaccines: the spike hypothesis","volume":"28","author":"Trougakos","year":"2022","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.virol.2026.110894_bib36","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.3390\/ijms25073943","article-title":"Design and Escherichia coli expression of a natively folded multi-disulfide bonded Influenza H1N1-PR8 receptor-binding domain (RBD)","volume":"25","author":"Tu","year":"2024","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virol.2026.110894_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/s41579-020-00468-6","article-title":"Coronavirus biology and replication: implications for SARS-CoV-2","volume":"19","author":"V\u2019kovski","year":"2021","journal-title":"Nat. Rev. Microbiol."},{"key":"10.1016\/j.virol.2026.110894_bib38","article-title":"The differentiation and maintenance of SARS-CoV-2-Specific follicular helper T cells","volume":"12","author":"Wang","year":"2022","journal-title":"Front. Cell. Infect. Microbiol."},{"key":"10.1016\/j.virol.2026.110894_bib39","doi-asserted-by":"crossref","first-page":"2676","DOI":"10.3390\/molecules29112676","article-title":"Non-Glycosylated SARS-CoV-2 omicron BA.5 Receptor Binding Domain (RBD) with a native-like conformation induces a robust immune response with potent neutralization in a mouse model","volume":"29","author":"Wongnak","year":"2024","journal-title":"Molecules"},{"key":"10.1016\/j.virol.2026.110894_bib40","doi-asserted-by":"crossref","DOI":"10.2142\/biophysico.bppb-v20.0036","article-title":"E. coli production of a multi-disulfide bonded SARS-CoV-2 Omicron BA.5 RBD exhibiting native-like biochemical and biophysical properties","volume":"20","author":"Wongnak","year":"2023","journal-title":"Biophysics and Physicobiology"},{"key":"10.1016\/j.virol.2026.110894_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241310583","article-title":"Antisera produced using an E. coli-Expressed SARS-CoV-2 RBD and complemented with a minimal dose of mammalian-cell-expressed S1 subunit of the spike protein exhibits improved neutralization","volume":"24","author":"Yoshizue","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.virol.2026.110894_bib42","article-title":"Why does COVID-19 continue to spread despite mass vaccination?","volume":"10","author":"Zhang","year":"2022","journal-title":"Front. Public Health"},{"key":"10.1016\/j.virol.2026.110894_bib43","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1038\/s41392-023-01557-7","article-title":"Vaccine adjuvants: mechanisms and platforms","volume":"8","author":"Zhao","year":"2023","journal-title":"Signal Transduct. Targeted Ther."}],"container-title":["Virology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226001091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0042682226001091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T17:16:36Z","timestamp":1776273396000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0042682226001091"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":43,"alternative-id":["S0042682226001091"],"URL":"https:\/\/doi.org\/10.1016\/j.virol.2026.110894","relation":{},"ISSN":["0042-6822"],"issn-type":[{"value":"0042-6822","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Omicron RBD expressed in E. coli outperforms mammalian-expressed S1 spike protein in generating highly neutralizing anti-SARS-CoV-2 antibodies in mice","name":"articletitle","label":"Article Title"},{"value":"Virology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.virol.2026.110894","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"110894"}}